Literature DB >> 1343606

Does episiotomy prevent perineal trauma and pelvic floor relaxation?

M C Klein1, R J Gauthier, S H Jorgensen, J M Robbins, J Kaczorowski, B Johnson, M Corriveau, R Westreich, K Waghorn, M M Gelfand.   

Abstract

OBJECTIVE: To compare the outcomes of the current practice of liberally or routinely employing episiotomy to prevent perineal tears and pelvic floor relaxation (control group) to a policy of restricting episiotomy use to specific fetal and maternal indications (experimental group).
DESIGN: A randomized controlled trial (RCT).
SETTING: Three university hospitals in Montreal.
SUBJECTS: Seven hundred three low-risk women enrolled at 30 to 34 weeks of gestation were randomized late in labor to the designated trial arm, by parity, and followed up to 3 months postpartum. MAIN OUTCOME MEASURES: Antepartum and postpartum information on perineal trauma and pain, pelvic floor symptoms (urinary incontinence), and sexual activity was collected through the use of standard questionnaires; pelvic floor function was measured by electromyographic (EMG) perineometry.
RESULTS: Restricting episiotomy use in primiparous women was associated with similar sutured perineal trauma to the liberal or routine approach. Multiparous women in the restricted episiotomy group more often gave birth with an intact perineum (31% compared with 19%, odds ratio (OR) = 1.85, 95% confidence interval (CI) = 1.09 to 3.16). All but one 3rd/4th-degree perineal tear was associated with median episiotomy (46 of 47 in primiparous women and 6 of 6 among multiparous women). No difference between trial groups was found in postpartum perineal pain, antepartum and 3-month postpartum EMG perineometry, and urinary and pelvic floor symptoms.
CONCLUSIONS: We found no evidence that liberal or routine use of episiotomy prevents perineal trauma or pelvic floor relaxation. Virtually all severe perineal trauma was associated with median episiotomy. Restriction of episiotomy use among multiparous women resulted in significantly more intact perineums and less perineal suturing.

Entities:  

Mesh:

Year:  1992        PMID: 1343606     DOI: 10.1097/00006254-199404000-00008

Source DB:  PubMed          Journal:  Online J Curr Clin Trials        ISSN: 1059-2725


  8 in total

1.  No episiotomy versus selective lateral/mediolateral episiotomy (EPITRIAL): an interim analysis.

Authors:  Lena Sagi-Dain; Rabia Bahous; Orna Caspin; Inna Kreinin-Bleicher; Ron Gonen; Shlomi Sagi
Journal:  Int Urogynecol J       Date:  2017-09-20       Impact factor: 2.894

2.  Episiotomy results stand despite lack of compliance.

Authors:  M C Klein
Journal:  CMAJ       Date:  1995-12-15       Impact factor: 8.262

3.  Anal incontinence after childbirth.

Authors:  Erica Eason; Michel Labrecque; Sylvie Marcoux; Myrto Mondor
Journal:  CMAJ       Date:  2002-02-05       Impact factor: 8.262

Review 4.  [Effectiveness of liberal vs. conservative episiotomy in vaginal delivery with reference to preventing urinary and fecal incontinence: a systematic review].

Authors:  Gabriele Schlömer; Mechthild Gross; Gabriele Meyer
Journal:  Wien Med Wochenschr       Date:  2003

5.  Physicians' beliefs and behaviour during a randomized controlled trial of episiotomy: consequences for women in their care.

Authors:  M C Klein; J Kaczorowski; J M Robbins; R J Gauthier; S H Jorgensen; A K Joshi
Journal:  CMAJ       Date:  1995-09-15       Impact factor: 8.262

Review 6.  Episiotomy for vaginal birth.

Authors:  Guillermo Carroli; Luciano Mignini
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

7.  Effects of carrying a pregnancy and of method of delivery on urinary incontinence: a prospective cohort study.

Authors:  Erica Eason; Michel Labrecque; Sylvie Marcoux; Myrto Mondor
Journal:  BMC Pregnancy Childbirth       Date:  2004-02-19       Impact factor: 3.007

8.  Pattern of episiotomy use & its immediate complications among vaginal deliveries in 18 tertiary care hospitals in India.

Authors:  Shalini Singh; Tushita Thakur; Nomita Chandhiok; Balwan Singh Dhillon
Journal:  Indian J Med Res       Date:  2016-04       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.